TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout timelines to just one year
Publications
New Study: Recently Approved Drug-Resistant TB Treatments Can Save National Governments up to US$740 Million Annually
PRETORIA (16 November, 2022)—A new study published in PLOS Global Public Health found that the BPaLM/BPaL treatment regimen that will
New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010
NEW YORK (28 January 2021)—The public-private initiatives that contributed to COVID-19 vaccine and drug development have showcased a model for